Atherosclerotic plaque
Showing 1 - 25 of 3,460
Atherosclerotic Plaque Development in Human
Not yet recruiting
- Coronary Heart Disease, Susceptibility to, 1
- No intervention
- (no location specified)
Jul 13, 2023
Pollutants in Atherosclerotic Plaque and Cardiovascular Events
Recruiting
- Atherosclerosis
- analysis of carotid atherosclerotic plaque
-
Naples, ItalyCelestino Sardu
Jun 12, 2023
Vulnerable Carotid Atherosclerotic Plaque: A Clinical
Recruiting
- Ultrasound
-
Hangzhou, Zhejiang, ChinaDepartment of Ultrasound, Second Affiliated Hospital, School of
Apr 28, 2023
Atherosclerosis of Artery Trial in Moscow (blood microRNA, plaque and intima microRNA, histological examination of the plaque)
Recruiting
- Atherosclerosis of Artery
- blood microRNA
- +3 more
-
Moscow, Russian FederationI.M. Sechenov First Moscow State Medical University (Sechenov Un
Jan 9, 2023
Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis Trial in Nanjing (Alirocumab, Atorvastatin)
Not yet recruiting
- Intracranial Atherosclerosis
- +2 more
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Oct 10, 2023
Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease Trial in Seoul (Rivaroxaban 2.5mg)
Recruiting
- Atherosclerosis of Artery
- +3 more
- Rivaroxaban 2.5mg
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 2, 2023
Carotid Plaque Imaging Project (CPIP)
Recruiting
- Atherosclerosis
- Atherosclerotic Plaque
- Observational study
-
Malmö, Skåne, SwedenSkåne University Hospital (SUS)
Apr 18, 2023
Prediction of Atherosclerotic Plaque Progression
Active, not recruiting
- Coronary Artery Disease
- OCT, NIRS
-
Prague, CzechiaNa Homolce Hospital
Jun 15, 2022
Dyslipidemias Trial in Samara (Combined Lipid-lowering Therapy)
Recruiting
- Dyslipidemias
- Combined Lipid-lowering Therapy
-
Samara, Russian FederationSamara Regional Cardiology Dispansery
Nov 17, 2022
Molecular Mechanisms and Carotid Atherosclerosis
Completed
- Diabetes Mellitus, Type 2
- +2 more
- statin Oral Tablet plus PCSK9i
-
Naples, ItalyRaffaele Marfella
Aug 1, 2022
Atherosclerotic Cardiovascular Disease Trial in Beijing (Naoxintong Capsule, Placebo)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Naoxintong Capsule
- Placebo
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences, Fuwai Hospital
May 18, 2022
Coronary Artery Disease, Atherosclerotic Plaque Trial in Los Angeles (18F-NaF PET and coronary CTA imaging)
Completed
- Coronary Artery Disease
- Atherosclerotic Plaque
- 18F-NaF PET and coronary CTA imaging
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 20, 2022
Carotid Artery Stenosis, Asymptomatic Carotid Artery Stenosis Trial in North York, Toronto (Evolocumab)
Recruiting
- Carotid Artery Stenosis
- Asymptomatic Carotid Artery Stenosis
-
North York, Ontario, Canada
- +2 more
Apr 29, 2022
Familial Hypercholesterolemia Trial in Madrid (Alirocumab)
Completed
- Familial Hypercholesterolemia
-
Madrid, SpainFundacion Hipercolesterolemia Familiar
Jul 15, 2022
Coronary Artery Calcifications by Whole Blood Transcriptome
Enrolling by invitation
- Atherosclerosis
- +2 more
-
Ciudad Autonoma de Buenos Aires, ArgentinaClinica Sagrada Familia
Nov 15, 2022
STabilization of Atheroma By Lipid-reducing Effect of
Not yet recruiting
- Coronary Artery Disease
- +2 more
- SeQuent Please Neo
-
Ansan-si, Gyeonggi-do, Korea, Republic ofKorea University Ansan Hospital
Jun 24, 2022
Brain-heart Interaction in Coronary Plaque Stability and
Recruiting
- Coronary Artery Disease
- CCTA and 18F-FDG-PET/CT
-
Beijing, China
- +3 more
Sep 15, 2022
TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid
Not yet recruiting
- TIA
- +2 more
- Interleukin-2 [IL-2]
- Standard care - Carotid Endarterectomy
-
Cambridge, Cambridgeshire, United KingdomAddenbrookes Hospital
Aug 2, 2023
Atherosclerosis, Coronary, Emotional Stress, Inflammation Trial in Seoul (OCT-FLIM (optical coherence tomography-fluorescence
Recruiting
- Atherosclerosis, Coronary
- +7 more
- OCT-FLIM (optical coherence tomography-fluorescence life time)
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Aug 22, 2022
Coronary Artery Disease Trial in Seoul (Rosuvastatin 10 mg plus ezetimibe 10 mg orally once a day, Rosuvastatin 20 mg orally
Recruiting
- Coronary Artery Disease
- Rosuvastatin 10 mg plus ezetimibe 10 mg orally once a day
- Rosuvastatin 20 mg orally once a day
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 10, 2021
Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume
Active, not recruiting
- Non-small Cell Lung Cancer
-
Boston, MassachusettsMassachusetts General Hospital
Sep 1, 2021
Carotid Atherosclerotic Plaque Load and Neck Circumference
Recruiting
- Atherosclerosis of Artery
- +2 more
-
Kadıköy, İstanbul, TurkeyIstanbul MEdeniyet University Göztepe Prof. Dr. Süleyman Yalçın
Sep 12, 2021
Stroke, Intracranial Atherosclerosis, High Resolution Magnetic Resonance Imaging Trial in Shenyang (Registration)
Recruiting
- Stroke
- +2 more
- Registration
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Jun 1, 2023
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Identifying Vulnerable CoronAry PLaqUes With Artificial
Enrolling by invitation
- Coronary Artery Disease
- Plaque, Atherosclerotic
- Intravascular imaging test
-
Nanjing, Jiangsu, ChinaResearch Institute Of Medical Imaging Jinling Hospital
Sep 5, 2023